Skip to the reading The hormone conversation Put the medicine before the pitch. My questions Browse briefings ＋ Get bearings The reading path Put a name to it Understand sermorelin Read an offer Read the adult evidence Judge a source Understand compounding Expect an assessment Check the care Compare ways to be seen Check the licence Read the whole bill Ask about payment cover Prepare to ask Ask about possible harm Notice reasons to pause Gather your questions ← Back to the reading path Read an offer Give each source the right job. The useful source is the one that answers the claim in front of you. A question to carry Which source answers this exact claim, and where does its answer stop? Put it in my notebook ↘ A learning path. No treatment steps. For the medicine’s approval history The published FDA record for sermorelin (Geref) sets out its old uses and approval dates. Those approvals had ended by June 18, 2009; the position was checked on September 28, 2026. Read FDA as the abbreviation for Food and Drug Administration. When an offer mentions approval, ask for the product name and the named use in the record. Read those beside the offer’s actual wording. For a claim about a benefit Ask to see the study behind it. Read what was measured and who took part. Keep a result about a related substance separate from a result about the medicine being offered. The Khorram adult study, for example, tested a substance closely related to sermorelin. Its chemical make-up had been changed, so it was not sermorelin itself; this research was reviewed on September 28, 2026. A record is useful within its limits. Read what it establishes, then ask what remains open. For the person or pharmacy Physician licence status and public disciplinary actions can be read through state medical boards. Even when a record shows no public action, it gives no grade for the care, as the medical boards’ consumer information explains. A National Drug Code (NDC) lets you find a product’s record in the FDA’s drug directory, a list of drug information. Having that record does not mean FDA checked the submitted details or approved the product, as of September 26, 2026. The FDA’s explanation of drug codes describes that limit. You can ask for a link and take time to read it. A source name spoken quickly during a sales call does not have to be the end of the conversation. ← Read the adult evidence Continue to understand compounding → Pick a question from the shelf. Get bearings Sort the names before you sort the options. Put a name to it ↗ Understand sermorelin ↗ Read an offer Keep a claim beside the evidence for it. Read the adult evidence ↗ Judge a source ↗ Understand compounding ↗ Expect an assessment ↗ Check the care Find the people, the process and the whole bill. Compare ways to be seen ↗ Check the licence ↗ Read the whole bill ↗ Ask about payment cover ↗ Prepare to ask Carry what remains unclear into the conversation. Ask about possible harm ↗ Notice reasons to pause ↗ Gather your questions ↗ Keep a question, leave the private details. Your question notebook Saving keeps these notes in this browser. Anyone using it may be able to read them. Leave out names and medical details. You can return to the same notebook from any briefing. Questions to carry with me Save my notes Erase my notes Saving is available when JavaScript is on. These pages are a guide for reading care offers and preparing questions; they do not provide appointments or sell medicines. Return to the reading path Browse by question Open my notebook